Aeolus Pharmaceuticals Inc AOLS:Over The Counter Market

Last Price$0.0008Over The Counter Market Previous Close - Last Trade as of 11:24AM ET 9/24/21
Over The Counter Market 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$0.0008 (233,770)
Ask (Size)$0.0060 (10,000)
Day Low / HighN/A - N/A
Volume2.00
 

View Biotechnology IndustryPeer Comparison as of 09/24/2021

 

Aeolus Pharmaceuticals Inc ( OTC )

Price: $0.0008
Change: 0.00 (0.00%)
Volume: 2.00
11:24AM ET 9/24/2021
 
 

VIA Pharmaceuticals Inc ( OTC )

Price: $0.00
Change: 0.00 (0.00%)
Volume: 266.00
3:20PM ET 11/30/2021
 
 

Panacos Pharmaceuticals Inc ( OTC )

Price: $0.0001
Change: 0.00 (0.00%)
Volume: 1.0 K
10:35AM ET 11/12/2021
 
 

QMed Inc ( OTC )

Price: $0.0006
Change: 0.00 (0.00%)
Volume: 75.00
11:35AM ET 5/24/2021
 
 

NanoLogix Inc ( OTC )

Price: $0.0002
Change: 0.00 (0.00%)
Volume: 11.1 K
1:23PM ET 12/03/2021
 

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionAeolus Pharmaceuticals, Inc. engages in the development of a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease, and diseases of the central nervous system. The company was founded by Brian J. Day in 1994 and is headquartered in Mission Viejo, CA. View company web site for more details
Address26361 Crown Valley Parkway
Mission Viejo, California 92691-7324
Phone+1.949.481.9825
Number of Employees4
President & Chief Executive OfficerJohn L. McManus

Company Highlights

Price Open$0.0008
Previous Close$0.0008
52 Week Range$0.0008 - 0.02
Market Capitalization$121.7 K
Shares Outstanding152.1 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.03
Beta vs. S&P 500N/A
Revenue$2.1 M
Net Profit Margin-531.00%
Return on Equity-245.74%

Analyst Ratings as of 06/26/2015

Buy
1
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset